Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Head and Neck Neoplasms × Proton Therapy × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 3 CNS 1

Conditions

Brain Neoplasms 11 Meningioma 6 Glioma 6 Glioblastoma 4 Pituitary Neoplasms 2 Oligodendroglioma 2 Gliosarcoma 2 Astrocytoma 2 Prostatic Neoplasms 1 Pinealoma 1 Neuroblastoma 1 Neurilemmoma 1 Nerve Sheath Neoplasms 1 Malignant Brain Glioma 1 Hemangiopericytoma 1 Head and Neck Neoplasms 1 Ganglioneuroblastoma 1 Ependymoma 1 Craniopharyngioma 1 Central Nervous System Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1

Interventions

Docetaxel 6 Radiotherapy 4 Filgrastim 4 Peripheral Blood Stem Cell Transplantation 3 Chemotherapy, Adjuvant 3 selpercatinib 2 sargramostim 2 Radiotherapy, Intensity-Modulated 2 Nivolumab 2 Gemcitabine 2 Etoposide 2 Cisplatin 2 Carboplatin 2 Capecitabine 2 Biopsy 2 Acupuncture Therapy 2 vocimagene amiretrorepvec 1 vandetanib 1 ulixertinib 1 tumor necrosis factor-alpha, CNGRC fusion protein, human 1 tanespimycin 1 spartalizumab 1 pentetreotide 1 pazopanib 1 oncogene protein E7, Human papillomavirus type 16 1 oblimersen 1 motexafin gadolinium 1 gallium Ga 68 dotatate 1 etoposide phosphate 1 erythromycin propionate-N-acetylcysteinate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05549414 2023-07-10

PPTS

P-Cure

Phase NA Unknown

Brain Neoplasms, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡